bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. Our objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.

Address

1733 TW Alexander Drive
RTP, NC 27709

Additional Details

Company Size:
1-9 Employees

Get In Touch

Phone:
508-361-3399
General Contact:
MDumas@bluebirdbio.com